---
title: "Centessa Pharmaceuticals Insider Sold Shares Worth $588,944, According to a Recent SEC Filing"
date: "2025-02-11 06:38:40"
summary: "Karen M. Anderson, Chief People Officer, on February 07, 2025, sold 30,955 shares in Centessa Pharmaceuticals  for $588,944. Following the Form 4 filing with the SEC, Anderson has control over a total of 54,322 common shares of the company, with 54,322 shares held directly. SEC Filing:www.sec.gov/Archives/edgar/data/1847903/000184790325000031/xslF345X05/wk-form4_1739226781.xml"
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Karen M. Anderson, Chief People Officer, on February 07, 2025, sold 30,955 shares in Centessa Pharmaceuticals for $588,944. Following the Form 4 filing with the SEC, Anderson has control over a total of 54,322 common shares of the company, with 54,322 shares held directly.

SEC Filing:

[www.sec.gov/Archives/edgar/data/1847903/000184790325000031/xslF345X05/wk-form4\_1739226781.xml](https://www.sec.gov/Archives/edgar/data/1847903/000184790325000031/xslF345X05/wk-form4_1739226781.xml)

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250210:A3313996:0/)
